FAC – Talk Bio

Lilly Opens AI Drug-Discovery Models to Biotechs for Free via TuneLab Platform

2 days ago talkbio0Tagged Antibodies, Aortic Valve Insufficiency, biotech startups, Drug Discovery, eli lilly, federated learning, Insitro, Machine Learning, Small Molecule, TuneLab

Eli Lilly; AI drug discovery; TuneLab; biotech startups; machine learning; small molecules; antibodies; data sharing; federated learning; Insitro

Clinical Roundup: Cardiff, VYNE and NewAmsterdam Report Key Trial Results in Multiple Disease Areas

1 month ago talkbio0Tagged Alzheimer 's disease, BROADWAY trial, Cardiff Oncology, Clinical Trials, Metastasis from malignant neoplasm of colon and/or rectum, Neoplasms, NewAmsterdam Pharma, onvansertib, Statistical Significance, Vyne

Cardiff Oncology; VYNE; NewAmsterdam Pharma; clinical trial updates; onvansertib; metastatic colorectal cancer; Alzheimer’s disease; BROADWAY trial; oncology; statistically significant results

NewAmsterdam’s pooled Phase 3 data; C4 seeks partners for solid tumor degrader

4 months ago talkbio0Tagged BROADWAY, Cardiovascular Diseases, LDL-C, NewAmsterdam, Obicetrapib, Pooled Sample

Pooled Sample, Obicetrapib, BROADWAY, NewAmsterdam, LDL-C, Cardiovascular Diseases

Biogen’s New Global Headquarters: Consolidating Operations in Cambridge

6 months ago talkbio0Tagged Biogen, Cambridge, ELAVL2 gene, headquarters, innovation, Kendall Square, Open

Biogen, Cambridge, Kendall Square, headquarters consolidation, innovation hub, 2028 opening

Harbour BioMed Launches Élancé Therapeutics to Develop Next-Generation Obesity Treatments

6 months ago talkbio0Tagged bispecific antibody technology, Élancé, Harbour BioMed, next-generation, Obesity

Harbour BioMed, Élancé Therapeutics, Obesity therapies, Bispecific antibody technology, Next-generation treatments

Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business

9 months ago talkbio0Tagged capsule (pharmacologic), China, Exit Strategy, expansion, gelatin, India, Lonza

Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy

Cleerly Secures $192M for Heart Attack-Predicting AI Technology

9 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Cleerly, Coronary Artery Scanning, Heart Disease

Cleerly, AI, Heart Disease, Coronary Artery Scanning, Funding

Booster Therapeutics Launches with $15 Million Funding to Pioneer Proteasome Activator Therapies for Neurodegenerative Diseases

11 months ago talkbio0Tagged DCLRE1B gene, Health Ventures, Holdings, multicatalytic endopeptidase complex, Nerve Degeneration, Neurodegenerative Disorders, Proteasome Activator Therapies, Protein Degradation, Metabolic

Proteasome activator therapies, Neurodegenerative diseases, Booster Therapeutics, Novo Holdings, Apollo Health Ventures, 20S proteasome, Protein degradation, Neurodegeneration